Market Access News | pharmaphorum

News

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for moderate-to-severe plaque psoriasis.

News

A person sat, bent over in the darkness of depression

Wellcome donates £2m to UK's digital mental health drive

Wellcome has provided £2m in additional funding to the MHRA and NICE for a project to build the use of digital mental health technologies in the NHS.

News

Novo Nordisk files Wegovy product that claimed rapid voucher

Novo Nordisk is using its recently awarded FDA priority voucher on a high-strength version of its obesity drug Wegovy.

News

Otsuka joins IgAN market with Voyxact approval in US

Otsuka has claimed FDA approval for its IgAN therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch.

News

Torso of doctor with surgical gloves holding prescription pill bottle in one hand and multiple $100 bills in the other

Latest Medicare pricing cuts promise $12bn in savings

The CMS has revealed the prices for the second batch of 15 drugs going through Medicare's negotiation process, promising net savings of 44% on 2024.

News

NICE backs NHS use of Autolus' leukaemia CAR-T

Hundreds of people with an aggressive leukaemia will be able to access a CAR-T therapy developed by UK biotech Autolus after a NICE recommendation.

Innovent gets OK for China's first home-grown IL-23p19 drug

Wellcome donates £2m to UK's digital mental health drive

Novo Nordisk files Wegovy product that claimed rapid voucher

Otsuka joins IgAN market with Voyxact approval in US

Latest Medicare pricing cuts promise $12bn in savings

NICE backs NHS use of Autolus' leukaemia CAR-T

MSD gets first FDA okay for oral PCSK9 cholesterol drug

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks